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Abstract
Objectives—Delirium disproportionately affects patients with dementia and is associated with 
adverse outcomes. The diagnosis of delirium superimposed on dementia (DSD), however, can be 
challenging due to several factors including the absence of caregivers or the severity of pre-
existing cognitive impairment. Altered level of consciousness has been advocated as a possible 
useful indicator of delirium in this population. Here we evaluated the performance of the 
Richmond Agitation and Sedation Scale (RASS) and the modified-RASS (m-RASS) – an ultra-
brief measure of the level of consciousness – in the diagnosis of DSD.
Design—Multicenter prospective observational study. RASS and m-RASS results were analysed 
together, labelled RASS/m-RASS).
Setting—Acute geriatric wards, inhospital rehabilitation, emergency department.
Participants—Patients 65 years and older with dementia.
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Measurements—Delirium was diagnosed with the Diagnostic and Statistical Manual of Mental 
Disorders, 4th edition (DSM-IV) or with the DRS-R-98 or with the 4AT. Dementia was detected 
with the Clinical Dementia Rating (CDR) Scale, the Short Form Informant Questionnaire on 
Cognitive Decline in the Elderly (IQCODE) or via the clinical records.
Results—Of the 645 patients included, 376 (58%) had delirium. According to the instrument 
used to evaluate delirium the prevalence was 66% with the 4AT, 23% with the DSM and 100% 
with the DRS-R-98. Overall a RASS/m-RASS score other than 0 was 70.5% sensitive (95% CI: 
65.9% – 75.1%) and 84.8% (CI: 80.5% – 89.1%) specific for DSD. Using a RASS/m-RASS value 
>+1 or <−1 as a cut-off, the sensitivity was 30.6% (CI: 25.9% – 35.2%) and the specificity was 
95.5% (CI: 93.1% – 98.0%). The sensitivity and the specificity did not greatly vary according to 
the method of delirium diagnosis and the dementia ascertainment, though the specificity was 
slightly higher when the DSM and the IQCODE were used.
Conclusion—In older patients admitted to different clinical settings the RASS and m-RASS 
analyzed as a single group had moderate sensitivity and very high specificity for the detection of 
DSD. Level of consciousness is therefore a valuable clinical indicator that should form part of 
delirium screening strategies, though for higher sensitivity other methods of assessment should be 
used.
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INTRODUCTION
Delirium is a common neuropsychiatric disorder and when it occurs in patients with 
dementia, this condition is referred to as delirium superimposed on dementia, or DSD.1 The 
prevalence of DSD ranges between 22% to 89% in community and hospital populations.1 It 
is associated with higher health care costs, worse functional outcomes, and higher mortality 
rates when compared to patients with dementia alone.1–5
It is recognized in clinical practice and research that it can be challenging to distinguish 
delirium from dementia, particularly when the dementia is severe.6 Tests of attention can be 
used to detect inattention in delirium, but performance on these tests is also commonly 
impaired in the presence of severe dementia.7 There is little research specifically addressing 
the issue of the best methods of detecting DSD. In a recent systematic review, we found that 
very few studies had specifically determined how existing assessment methods perform in 
the diagnosis of DSD.8 Of 1,569 participants analyzed in the systematic review, 401 had 
dementia, and 50 had delirium superimposed on dementia. Six delirium tools were 
evaluated. The survey found a small evidence to support the CAM and the CAM-ICU to 
detect DSD in the general ward and ICU settings, respectively. With respect to specialists’ 
opinions, Richardson and colleagues performed a survey and found 41% of responders (N = 
85) felt that it was always possible to distinguish delirium from Behavioral and 
Psychological Symptoms in Dementia (BPSD), while 48% (N = 118) felt that this was only 
possible in some circumstances.6 However, the majority of responders believed that motor 
fluctuations and/or altered level of consciousness were important for the diagnosis of DSD. 
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In those who did use a specific test for level of consciousness, the Richmond Agitation and 
Sedation Scale (RASS) was the most popular in both clinical practice and research studies.6
The RASS was developed by Sessler and validated by Ely and colleagues as a measure of 
arousal, sedation, and level of consciousness in critically ill patients (Table 1).9, 10 The 
RASS has been recently modified and adapted for use in general wards (i.e. the modified 
RASS or m-RASS).11 Both the RASS and the m-RASS are ultra-brief assessments of the 
level of consciousness and recent studies have suggested that they have high specificity for 
delirium in geriatrics wards and emergency department.11–13 Leonard and colleagues14 
recently reported how delirium can be distinguished from dementia by virtue of the 
disproportionate impairment of vigilance and attention.
Because the RASS and the m-RASS simply require the rater to observe the patient and no 
collateral history is needed, they may be particularly useful in detecting delirium in patients 
with dementia, especially when the patient’s cognitive baseline (pre-existing attention or 
other cognitive deficits, determining acute onset and fluctuations etc.) is difficult to 
establish. However, patients in the advanced stages of dementia may be more likely to have 
baseline impairments in level of consciousness,15, 16 and so the specificity of the RASS may 
be decreased. Therefore we sought to determine, in a multicenter prospective cohort study, 
the diagnostic performances of the RASS and the m-RASS for the detection of delirium in 
older patients with dementia admitted to different clinical settings (i.e., acute geriatric wards, 
inhospital rehabilitation, emergency department).
METHODS
Sample and study design
This was a multicenter secondary analysis of previous prospective cohort studies that have 
evaluated delirium in patients with dementia. The local institutional review board or 
appropriate ethics committee in each institution reviewed and approved this study. The 
pooled dataset is derived from five different groups in different clinical settings (Table 1). 
The dataset consists of 645 patients with dementia.
Group 1 (N=114): this group was drawn from a prospective multicenter study designed to 
evaluate the performance of various attention tests in different subgroup of older patients 
(i.e. patients without delirium and dementia; patients with delirium only; patients with 
dementia only; patients with delirium and dementia). Patients were enrolled in different 
clinical settings in four European Countries: old-age psychiatry consultation-liaison 
(University of Limerick, Ireland); inpatient Rehabilitation (Department of Rehabilitation, 
Fondazione Camplani, Cremona, Italy); acute geriatric ward (San Gerardo Hospital, Monza, 
Italy); general surgery and orthopedic surgery (University of Basel, Switzerland); psychiatric 
ward and acute geriatric ward (Centro Hospitalar e Universitário de Coimbra, Portugal). In 
this group delirium was diagnosed using the Diagnostic and Statistical Manual of Mental 
Disorder, 5th Edition (DSM-5), and dementia was ascertained using the Short Form-
Informant Questionnaire on Cognitive Decline in the Elderly (SF-IQCODE).
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Group 2 (N=404): this group of patients was drawn from patients admitted to the acute 
geriatric ward of the San Gerardo Hospital, Monza, Italy May 2015 and May 2015. In this 
group of patients delirium was diagnosed using the 4 “A”s Test (4AT)17 and dementia was 
ascertained using the clinical records.
Group 3 (N=35): this group included only patients with delirium and dementia admitted to 
an inhospital rehabilitation unit. This population has been previously described.18, 19 The 
presence of dementia was determined by reviewing patient medical records. Additionally, 
two expert neuropsychologists confirmed and rated the severity of dementia by interviewing 
the caregivers at the time of enrollment using the Clinical Dementia Rating (CDR) Scale20 
and the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE), with a cut-
off of 3.3 used to indicate cognitive impairment.21 Delirium was diagnosed with the 
Diagnostic and Statistical Manual of Mental Disorders (4th edition, text revision) (DSM-IV-
TR) criteria, using a standardized approach.17
Group 4 (N=40): this group was previously described in Jabbar et al.22 In this group, 
delirium was diagnosed with the DRS-R-98, while dementia was defined as the presence of 
persistent cognitive impairment for at least six months prior to the assessment and/or DSM-
IV criteria based on all available information at the time of assessment including clinical 
case notes and collateral history from family and/or carers.
Group 5 (N=39): The fifth group of patients has also been previously described.12 In this 
group were included older patients admitted to an academic, tertiary care emergency 
department July 2009 to February 2012. Delirium was diagnosed using a comprehensive 
consultation-liaison psychiatrist assessment with the DSM-IV-TR criteria, while dementia 
was ascertained using the clinical records and IQCODE.
In each of these studies the modified-Richmond Agitation and Sedation Scale (m-RASS)11 
(Groups 1 and 3) or the Richmond Agitation and Sedation Scale (RASS) (Groups 2, 4 and 5) 
was performed.9, 10 The RASS9, 10 is a commonly used in the ICU to assess arousal, level of 
sedation and consciousness (Table 1). It ranges from –5 (unarousable) to + 4 (combative), 
and 0 indicates a normal level of alertness. The m-RASS11 also ranges from −5 
(unarousable) to + 4 (combative). The scale was modified to be used in non-ICU wards and 
it includes an element of judgment regarding attention, which is different from the RASS.
Statistical analysis
Continuous variables are reported as medians and interquartile ranges (IQRs) and 
categorical variables as proportions. RASS and m-RASS results were analyzed together, 
labeled RASS/m-RASS. Sensitivities, specificities, positive likelihood ratios, and negative 
likelihood ratios with their 95% confidence intervals (95% CIs) were calculated, stratifying 
according to the delirium (i.e., DSM-5, 4AT, DRS-R-98) and dementia evaluation 
(IQCODE-SF, CDR, clinical records). Diagnostic performances were calculated for three cut 
points: 1) a RASS/m-RASS other than 0 (RASS/m-RASS > 0 or < 0); 2) a RASS/m-RASS > 
+1 or < –1. All statistical analyses were performed using SAS version 9.4 (SAS Institute, 
Carey, NC).
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RESULTS
The study included a total of 645 patients with dementia. The median age was 84 
(Interquartile Range, IQR: 78, 89) (Table 3). 376 (58%) patients had delirium according to 
the reference standard assessments. The prevalence of delirium was 29.8% in the Group 1, 3, 
and 5 where the DSM was used to assess for delirium, 63.9% in Group 4 where the 4AT was 
used to assess for delirium. Finally in the Group 5 the prevalence of delirium was 100% 
since it included only patients with delirium assessed with the DRS-R-98). Dementia 
prevalence was 70.9% in Group 2 and 4 where the clinical records were used to assess for 
dementia prevalence, 23.7% in Group 1 and 5 where the IQCODE was used to assess for 
dementia. In Group 3 the prevalence of dementia was 100% since it included patients with 
dementia evaluated with the CDR.
Figure 1 shows the proportion of delirious patients according to the RASS/m-RASS score. 
Patients with a RASS/m-RASS score ≤ 4 are not shown since are not considered assessable 
for delirium.
The diagnostic performances of the RASS/m-RASS for the overall population can be seen in 
Table 4. A RASS/m-RASS other than 0 was 70.5% (95%CI: 65.9% – 75.1%) sensitive and 
84.8% (95%CI: 80.5% – 89.1%) specific. The specificity of the RASS/m-RASS 
incrementally increased with higher degrees of impairment increasing to 95.5% with a 
RASS/m-RASS value >+1 or <−1 but at the expense of sensitivity.
When stratified by delirium reference standard, the specificities of each RASS/m-RASS cut-
off were remarkably consistent. However, the RASS/m-RASS’ sensitivity was more variable 
based upon the delirium reference standard used. For example, a RASS/m-RASS other than 
0 was 62.5% (95% CI: 56.5% – 68.5%) when the 4AT was used as the delirium reference 
standard, whereas the sensitivity was 92.5% with the DRS-R-98. The sensitivity and 
specificity of the RASS/m-RASS remained consistent also when stratified by care location 
(Appendix 1).
The RASS/m-RASS’ specificities for all cut-offs were also similar between dementia 
ascertainment methods. However, the RASS/m-RASS’ sensitivity was more variable based 
upon the dementia ascertainment method used. For a RASS/m-RASS other than 0, the 
sensitivity was 66.7% (95% CI 53.2% – 84.0%) when the CDR was used to define patients 
with dementia, whereas the sensitivity was 92.5% (95% CI: 85.3% to 99.6%) when the SF-
IQCODE was used.
DISCUSSION
In this multicenter prospective cohort study we found the RASS/m-RASS, analyzed in a 
combined dataset, to be specific for the diagnosis of DSD in older patients admitted to acute 
geriatric wards, inhospital rehabilitation, emergency department, especially in patients with 
higher degrees of impaired level of consciousness (RASS/m-RASS value >+1 or <−1). 
Overall a RASS/m-RASS score other than 0 had a good specificity which progressively 
increased with a RASS/m-RASS value >+1 or <−1. The RASS/m-RASS’ specificity did not 
greatly vary according to the method of delirium diagnosis and the dementia ascertainment, 
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though the sensitivity was slightly higher when the DSM and the SF-IQCODE were used to 
diagnose delirium and to detect the presence of dementia, respectively.
Our findings are in line with previous studies investigating the accuracy of the RASS and the 
m-RASS for the detection of delirium.11–13 However, none of the previous studies has 
focused specifically on patients with delirium and dementia. Han and colleagues12 found a 
RASS score other than 0 to have a very good sensitivity (84%, 95% CI: 73.8% to 94.2%) 
and specificity (87.6%, 95 % CI: 84.2% to 91.1%) for the detection of delirium in 406 older 
patients admitted to an emergency department (ED). Interestingly, a RASS score > +1 or < –
1 was nearly diagnostic for delirium in this population,12 providing the busy ED setting with 
a fast and valuable tool for the screening-diagnosis of delirium. Two other studies have 
investigated the performance of the RASS for delirium assessment in other clinical settings. 
Chester and colleagues reported that any abnormal m-RASS score in a single-day evaluation 
had high specificity for delirium detection in 95 older medical patients.11 The specificity 
increased to 99.6% and the sensitivity fell to 34% when considering an abnormal m-RASS 
≥2 or ≤2.11 In 30 acute hip fracture older patients the RASS had a high sensitivity and 
specificity for delirium.13 The high specificity and lower sensitivity of the RASS/m-RASS 
in our study is similar to the study of Chester and colleagues,11 with higher RASS/m-RASS 
scores almost diagnostic for delirium. These findings are also supported by findings from the 
initial 4AT validation study, in which the binary level of alertness item (normal/abnormal) 
showed 96.1% specificity and 53.2% sensitivity for delirium in an inpatient geriatric 
population.17
The findings are of interest considering the difficulties in the detection of delirium in 
patients with dementia and they also reflect previous investigation evaluating the fluctuation 
of motor performances for the detection of delirium. Indeed the RASS/m-RASS are 
measures of arousal, level of sedation and consciousness. However, the negative and positive 
scores have also been used to characterize motor performances in patients with 
delirium.18, 19, 23 Motor performances have indeed been shown in previous investigations to 
be useful for DSD detection. Bellelli reported a clear change in the functional status of older 
patients with DSD and with a recovery after delirium resolution.24 Similarly, Meagher and 
colleagues found a higher prevalence of motor retardation and agitation in patients with 
DSD compared to patients with dementia alone.25 Interestingly, Voyer26 recently validated 
the RADAR, a new delirium screening tool for hospital and nursing home including patients 
with dementia. The tool requires the nurse evaluating the patients to answer three questions 
while administering the medications 1) Was the patient drowsy?; 2) Did the patient have 
trouble following your instructions?; 3) Were the patient’s movements slowed down? In the 
validation study item 3 (i.e. were the patient’s movements slowed down) was the item most 
commonly listed as positive (88%).26 The importance of motor fluctuations in the evaluation 
of patients with dementia has also been acknowledged in a recent survey of delirium 
experts.8 Most of the responders have indicated the RASS as a possible measure of motor 
fluctuation but to date there is not a clear indication. Indeed others have indicated the 
Glasgow Coma Scale or the Observational Scale of Level of Arousal (OSLA)13 as 
alternative measures of motor fluctuation. Additionally the easy of use of the RASS could 
indeed promote its application for a rapid first evaluation of delirium or for chart review 
purposes. Indeed, the m-RASS has been advocated for its simplicity and brevity to be used 
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in delirium prediction models.27 The RASS has also been shown to be a good marker of 
negative outcomes (i.e., hospital stay, discharge to skilled nursing facility, and mortality) in 
critically ill patients and acute medical older patients.28–30
Flaherty and colleagues have previously suggested the importance of including the 
assessment of the mental status as the sixth vital sign.31 It is well accepted to measure daily 
blood pressure, heart rate, respiratory rate, temperature and pain but it is not a standard of 
care to include a measure of mental status. Alertness was suggested as a simple way to 
evaluate mental status at the bedside, increasing the attention of health care providers to the 
detection of delirium and its management. The RASS/m-RASS might be well suitable for 
this scope, given the easy of its use and its ability to signaling delirium, especially in 
dementia patients. Indeed there has been a proposal to use a pictorial representation of the 
RASS using older male patients’ faces to facilitate the use of this scale by a wide range of 
health care providers.32 Therefore future studies should further evaluate the possibilities to 
integrate this proposed method similarly to the visual analogic scale for pain evaluation.
Other authors have also tried to increase the detection of delirium providing medical 
personnel with screening methods. Measures of inattention – a cardinal feature of delirium-
have been proposed for this purpose. Indeed the “months of the year backwards" was found 
to have a sensitivity of 83% (95% confidence interval [CI]: 69%–93%) and specificity of 
69% (95% CI: 61%–76%) for delirium detection.33 The best 2-item screen was the 
combination of "months of the year backwards" and "what is the day of the week?" with a 
sensitivity of 93% (95% CI: 81%–99%) and specificity of 64% (95% CI: 56%–70%).33 In 
another study the simultaneous evaluation of the “months of the year backwards" and the 
assessment for subjective/objective confusion provided a sensitivity of 93.8% (95% CI: 
82.8%–98.6%) and a specificity of 84.7% (95% CI: 79.2%–89.2%).34 Nonetheless, patients 
with severe inattention might not be formally evaluated with the use of tests such as the 
“months of the year backwards" leading clinicians to consider these patients as untestable 
with the risk of missing delirium in the most severe cases. The use of the RASS/m-RASS as 
a screening method might overcome these limitations.
Our study has important strengths. This is the first multicenter observational study 
evaluating the performances of the RASS and m-RASS for the detection of delirium in a 
large group of patients with dementia in different clinical settings. The diagnosis of delirium 
was carried out with rigorous evaluations. We were able to compare the performances of the 
RASS and m-RASS using different tools to diagnose delirium and with different methods to 
evaluate the presence of dementia. Limitations of the study include a greater number of 
patients evaluated with the 4AT. However, this tool has been validated against the DSM-IV 
criteria and indeed the findings of the performance of the RASS/m-RASS to detect delirium 
were similar when the 4AT and DSM criteria were used.
CONCLUSION
In older patients admitted to different clinical settings the RASS and/or m-RASS are useful 
tools for delirium screening in patients with dementia. A RASS/m-RASS score other than 0 
has moderate sensitivity and high specificity for the detection of delirium in patients with 
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dementia. The accuracy of the tests increases with a higher degree of impairment of level of 
consciousness. The sensitivity and the specificity did not greatly vary according to the 
method of delirium diagnosis and the dementia ascertainment, though the specificity was 
slightly higher when the DSM and the SF-IQCODE were used to diagnose delirium and to 
detect the presence of dementia. The RASS or m-RASS are very quick and should be part of 
delirium screening strategies in routine practice. However, because the sensitivity is only 
moderate (because not all patients with DSD have altered level of consciousness), additional 
methods such as informant history and cognitive testing would increase the rates of 
detection.
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Figure 1. 
Proportion of delirious patients according to the RASS/m-RASS score. Patients with a 
RASS/m-RASS score ≤ 4 are not shown since are not considered assessable for delirium.
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Table 1
The Richmond Agitation and Sedation Scale (RASS)9, 10 and the modified Richmond Agitation and Sedation 
Scale (m-RASS).11
Score RASS m-RASS
+4 Combative: Combative, violent, immediate
danger to staff
Combative: No attention; overtly
combative, violent, immediate danger to staff
+3 Very agitated: Pulls to remove tubes or
catheters, aggressive
Very agitated: Very distractible; repeated
calling or touch required to get or keep eye
contact or attention; cannot focus; pulls or
removes tube(s) or catheter(s); aggressive;
fights environment not people
+2 Agitated: Frequent non-purposefeul
movement, fight ventilator
Slightly agitated: Easily distractible; rapidly
loses attention; resists care or uncooperative;
frequent non-purposeful movement
+1 Restless: Anxious, apprehensive,
movements non aggressive
Restless: Slighlty distactrible; pays attention
most of the time; anxious, but cooperative;
movements non aggressive or vigorous
0 Alert and Calm: Spontaneously pays
attention to caregiver
Alert and Calm: Pays attention; makes eye
contact, aware of surroundings; responds
immediately and appropriately to calling
name and touch
−1 Drowsy: Not fully alert, but has sustained
awakening to voice (eye opening & contact
>10 sec)
Wakes easily: Slightly drowsy; eye
contact >10 sec; not fully alert, but has
sustained awakening; eye opening/eye
contact to voice >10 seconds
−2 Light sedation: Briefly awakens to voice
(eyes open & contact
Wakes slowly: Very drowsy; pays attention
some of the time; briefly awakens with eye
contact to voice < 10 seconds
−3 Moderate sedation: Movement or eye
opening to voice (no eye contact)
Difficult to wake: Repeated calling or touch
required to get or keep eye contact or
attention; needs repeated stimuli (touch or
voice) for attention, movement, or eye
opening to voice (but no eye contact)
−4 Deep sedation: No response to voice, but
movement or eye opening to physical
stimulation
Can’t stay awake: Arousable but no
attention; no response to voice, but
movement or eye opening to physical
stimulation
−5 Unarousable: No response to voice or
physical stimulation
Unarousable: No response to voice or
physical stimulation
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Table 2
Description of setting, delirium assessment and dementia ascertainment according to the enrollment site
Enrollment Setting Delirium
diagnosis
Diagnosis of dementia
Group 1
-Cremona (Italy) Inhospital rehabilitation DSM-IV SF-IQCODE
-Limerick (Ireland) Old-age psychiatry
consultation-liaison
DSM-IV SF-IQCODE
-Coimbra (Portugal) Psychiatry, acute geriatric
ward
DSM-IV SF-IQCODE
-Basel (Switzerland) General surgery and
orthopedic surgery
DSM-IV SF-IQCODE
-Monza (Italy) Acute geriatric ward DSM-IV SF-IQCODE
Group 2
Monza (Italy) Acute geriatric ward 4AT Clinical records
Group 3
Cremona (Italy) Inhospital rehabilitation DSM-IV Clinical Dementia Rating
Scale (CDR)
Group 4
Limerick (Ireland) Palliative care DRS-R-98 Clinical records
Group 5
Nashville (TN, USA) Emergency Department DSM-IV SF-IQCODE
Short Form Informant Questionnaire on Cognitive Decline in the Elderly (SF-IQCODE).
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Table 3
Patient characteristics for all patients and stratified by delirium.
Variable All Patients
N=632
Delirium Negative
n=265
Delirium Positive
n=367
Median Age (IQR) 84 (78, 89) 82 (77, 88) 85 (80, 89)
Gender
  Female 405 (64.1%) 169 (63.8%) 235 (64.1%)
  Male 227 (35.9%) 96 (36.2%) 134 (36.5%)
Enrollment Site
  Basel (Switzerland) 5 (0.8%) 1 (0.4%) 4 (1.1%)
  Coimbra (Portugal) 14 (2.2%) 7 (2.6%) 7 (1.9%)
  Cremona (Italy) 49 (7.8%) 7 (2.6%) 42 (11.4%)
  Limerick (Ireland) 54 (8.5%) 7 (2.6%) 47 (12.8%)
  Monza (Italy) 411 (59.9%) 165(39.9%) 246 (67.0%)
  Nashville (USA) 99 (15.7%) 78 (29.0%) 21 (5.7%)
Dementia Method
  CDR 35 (5.5%) 0 (0.0%) 35 (9.5%)
  Clinical Records 444 (70.3%) 165 (62.3%) 279 (76.0%)
  SF-IQCODE 153 (23.2%) 100 (37.7%) 53 (14.4%)
Delirium Reference Standard
  4AT 404 (63.9%) 165 (62.3%) 239 (65.1%)
  DRS-R-98 40 (6.3%) 0 (0.0%) 40 (10.9%)
  DSM 188 (29.8%) 100 (37.7%) 88 (24.0%)
RASS/m-RASS score
  RASS/m-RASS =0 339 (53.6%) 228 (86.0%) 111 (30.3%)
  RASS/m-RASS = −1 129 (20.4%) 26 (9.8%) 103 (28.1%)
  RASS/m-RASS = −2 40 (6.3%) 4 (1.5%) 36 (9.8%)
  RASS/m-RASS = −3 14 (2.2%) 3 (1.1%) 11 (3.0%)
  RASS/m-RASS = +1 50 (7.9%) 3 (1.1%) 47 (12.8%)
  RASS/m-RASS = +2 42 (6.7%) 1 (0.4%) 41 (11.2%)
  RASS/m-RASS= +3 12 (1.9%) 0 (0.0%) 12 (3.3%)
  RASS/m-RASS= +4 6 (1.0%) 0 (0.0%) 6 (1.6%)
Abbreviations: Clinical Dementia Rating (CDR) Scale; Short Form Informant Questionnaire on Cognitive Decline in the Elderly (SF-IQCODE); 
Diagnostic and Statistical Manual of Mental Disorders (DSM); Delirium Rating Scale-Revised (DRS-R-98)
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